Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRYSTALLINE (2S) -3- [ (3S, 4S) -3- [ (1R) -1-HYDROXYETHYL] -4- (4-METHOXY-3- { [1- (5-METHYLPYRIDIN-2-YL) AZETIDIN-3-YL] OXY} PHENYL) -3-METHYLPYRROLIDIN-1-YL] -3-OXOPROPANE-1, 2-DIOL
Document Type and Number:
WIPO Patent Application WO/2016/033776
Kind Code:
A1
Abstract:
Provided are crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{[1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy}phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol, pharmaceutical compositions thereof and the use of the compound to treatment of overactive bladder.

Inventors:
HUANG PING (US)
RIBE SETH DIETRICH (US)
Application Number:
PCT/CN2014/085925
Publication Date:
March 10, 2016
Filing Date:
September 04, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LILLY CO ELI (US)
LILLY CHINA RES AND DEV CO LTD (CN)
International Classes:
C07D403/14; A61K31/4025; A61P13/10
Domestic Patent References:
WO2001047905A12001-07-05
WO2014159012A12014-10-02
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (Great Eagle Center23 Harbour Road,Wanchai, Hong Kong, CN)
Download PDF: